| MolName | (E)-2-(1,3-benzothiazol-2-yl)-3-[3-(4-morpholin-4-ylsulfonylphenyl)-1-phenylpyrazol-4-yl]prop-2-enenitrile |
| MolecularFormula | C29H23N5O3S2 |
| Smiles | N#C/C(/c1nc(cccc2)c2s1)=C\c1cn(-c2ccccc2)nc1-c(cc1)ccc1S(N1CCOCC1)(=O)=O |
| InChI | InChI=1S/C29H23N5O3S2/c30-19-22(29-31-26-8-4-5-9-27(26)38-29)18-23-20-34(24-6-2-1-3-7-24)32-28(23)21-10-12-25(13-11-21)39(35,36)33-14-16-37-17-15-33/h1-13,18,20H,14-17H2 |
| InChIK | ZJNWYSMKVPSJFF-UHFFFAOYSA-N |
| TotalMolweight | 553.666 |
| Molweight | 553.666 |
| MonoisotopicMass | 553.12423 |
| CLogP | 3.3016 |
| CLogS | -4.612 |
| H Acceptors | 8 |
| TotalSurfaceArea | 406.64 |
| Relative PSA | 0.25787 |
| PolarSurfaceArea | 137.73 |
| Druglikeness | 1.6078 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.46154 |
| Fragments | 1 |
| Non HAtoms | 39 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| Rotatable Bond | 5 |
| Rings Closures | 6 |
| Small Rings | 6 |
| Aromatic Rings | 5 |
| Aromatic Atoms | 26 |
| Sp3Atoms | 6 |
| Symmetricatoms | 7 |
| Amides | 1 |
| Aromatic Nitrogens | 3 |
| StereoCon |
Click to Load Molecule:
1 - (E)-2-(1,3-benzothiazol-2-yl)-3-[3-(4-morpholin-4-ylsulfonylphenyl)-1-phenylpyrazol-4-yl]prop-2-enenitrile | 2 - (E)-2-(1,3-benzothiazol-2-yl)-3-[3-(4-morpholin-4-ylsulfonylphenyl)-1-phenylpyrazol-4-yl]prop-2-enenitrile